Back
ESC Premium Access

Edoxaban treatment of elderly patients with atrial fibrillation in routine clinical practice: 1-year results of the non-interventional Global ETNA-AF program

Session: Abstract Programme
Topic: Oral Anticoagulation
Speaker: Doctor T. Yamashita (Tokyo, JP)
Event: ESC Asia with APSC & AFC 2020

Congress Presentation

Add to my library

Like

About the speaker

Doctor Takeshi Yamashita

The Cardiovascular Institute, Tokyo (Japan)
0 follower

238 more presentations in this session

2-year real-world outcomes of prasugrel, ticagrelor or clopidogrel therapy following percutaneous coronary intervention from a large multi-centre Australian registry.

Speaker: Doctor D. Pol (Melbourne, AU)

Access
Abstract
Like
Thumbnail

3D right ventricular ejection fraction and longitudinal strain are independent predictors of major adverse cardiovascular events in patients with rrhythmogenic right ventricular cardiomyopathy

Speaker: Assistant Professor L. Hosseini (Bojnurd, IR)

Access
Abstract
Like
Thumbnail

A novel pressure-regulated deployment strategy for improving the safety and efficacy of balloon-expandable transcatheter aortic valves

Speaker: Doctor A. Snir (Sydney, AU)

Access
Abstract
Video
Like
Thumbnail

A novel therapeutic approach for coronary inflammation and lymphatic vessels using non-invasive low-intensity pulsed ultrasound in a porcine model with DES-induced coronary hyperconstricting responses

Speaker: Doctor T. Watanabe (Sendai, JP)

Access
Abstract
Video
Like
Thumbnail

A real-world comparison of outcomes between fractional flow reserve-guided versus angiography-guided percutaneous coronary intervention

Speaker: Doctor C. Wong (Sydney, AU)

Access
Abstract
Like
Thumbnail

Access the full session

Abstract Programme

Speakers: Doctor T. Yamashita, Doctor D. Pol, Assistant Professor L. Hosseini, Doctor A. Snir, Doctor T. Watanabe...
Access
Like
Thumbnail

About the event

Image

ESC Asia with APSC & AFC 2020

3 December - 5 December 2020

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources